Mortality (n = 1164) | Survival (n = 8790) | |
---|---|---|
Gender, No. (%) | ||
Male | 658 (56.53) | 5118 (58.23) |
Female | 506 (43.47) | 3672 (41.77) |
Age, median (IQR), y | 73.51 (63.16–80.36) | 66.99 (57.35–76.23) |
Race/ethnicity, No. (%) | ||
White non-hispanic | 762 (65.46) | 5879 (66.88) |
Black non-hispanic | 117 (10.05) | 1045 (11.89) |
Hispanic | 39 (3.35) | 382 (4.35) |
Asian | 23 (1.98) | 199 (2.26) |
Other | 223 (19.16) | 1285 (14.62) |
Hospital LOS, median (IQR), d | 6.27 (2.07–13.76) | 7.29 (4.56–12.10) |
Max subscores in the first 72 h, median (IQR) | ||
Respiration | 2 (0–3) | 0 (0–2) |
Coagulation | 0 (0–1) | 0 (0–1) |
Hepatic | 0 (0–1) | 0 (0–0) |
Cardiovascular | 1 (1–4) | 1 (1–1) |
Neurologic | 3 (2–4) | 2 (0–4) |
Renal | 1 (0–2) | 0 (0–1) |
SAPS II, median (IQR) | 50 (39–61) | 33 (26–42) |
APS III, median (IQR) | 63.5 (48–81) | 40 (31–53) |
SOFA_mean in the first 7 days, median (IQR) | 6.67 (4.33–9.4) | 3 (1.71–4.67) |
SOFA_median in the first 7 days, median (IQR) | 7 (4–10) | 3 (1.5–5) |